Blood thinner safety check in kids after heart surgery
NCT ID NCT06193863
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study looks at children with congenital heart disease who take the blood thinner rivaroxaban after a Fontan procedure. The goal is to see how often serious or minor bleeding happens. Researchers will collect data from regular doctor visits for up to 2 years. No extra tests or visits are required.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDREN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Many Locations
Many Locations, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart surgery in childhood: a hidden impact on speech and memory?
- Hidden heart risks in Wilson's disease: a new scan could spot them early
- A website designed to steer teens with heart defects away from vaping
- AI stethoscope aims to spot hidden heart and lung problems in children
- Can a new formula save more children from severe malnutrition?
- Can community hospitals in zambia master severe disease care?